Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice

Ischemia‐reperfusion (I/R) injury is a process whereby an initial hypoxic insult and subsequent return of blood flow leads to the propagation of innate immune responses and organ injury. The necessity of the pattern recognition receptor, Toll‐like receptor (TLR)4, for this innate immune response has been previously shown. However, TLR4 is present on various cell types of the liver, both immune and nonimmune cells. Therefore, we sought to determine the role of TLR4 in individual cell populations, specifically, parenchymal hepatocytes (HCs), myeloid cells, including Kupffer cells, and dendritic cells (DCs) subsequent to hepatic I/R. When HC‐specific (Alb‐TLR4−/−) and myeloid‐cell–specific (Lyz‐TLR4−/−) TLR4 knockout (KO) mice were subjected to warm hepatic ischemia, there was significant protection in these mice, compared to wild type (WT). However, the protection afforded in these two strains was significantly less than global TLR4 KO (TLR4−/−) mice. DC‐specific TLR4−/− (CD11c‐TLR4−/−) mice had significantly increased hepatocellular damage, compared to WT mice. Circulating levels of high‐mobility group box 1 (HMGB1) were significantly reduced in Alb‐TLR4−/− mice, compared to WT, Lyz‐TLR4−/−, CD11c‐TLR4−/− mice and equivalent to global TLR4−/− mice, suggesting that TLR4‐mediated HMGB1 release from HCs may be a source of HMGB1 after I/R. HCs exposed to hypoxia responded by rapidly phosphorylating the mitogen‐activated protein kinases, c‐Jun‐N‐terminal kinase (JNK) and p38, in a TLR4‐dependent manner; inhibition of JNK decreased release of HMGB1 after both hypoxia in vitro and I/R in vivo. Conclusion: These results provide insight into the individual cellular response of TLR4. The parenchymal HC is an active participant in sterile inflammatory response after I/R through TLR4‐mediated activation of proinflammatory signaling and release of danger signals, such as HMGB1. (HEPATOLOGY 2013)

[1]  T. Billiar,et al.  Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. , 2012, Gastroenterology.

[2]  M. Kay,et al.  Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. , 2011, The Journal of clinical investigation.

[3]  R. Schnellmann,et al.  Toll‐like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  C. Esmon,et al.  Endogenous Histones Function as Alarmins in Sterile Inflammatory Liver Injury Through Toll-like Receptor 9 in Mice , 2011, Hepatology.

[5]  T. Billiar,et al.  Interferon Regulatory Factor 1 Mediates Acetylation and Release of High Mobility Group Box 1 from Hepatocytes During Murine Liver Ischemia-Reperfusion Injury , 2011, Shock.

[6]  Jason P. Zlotnicki,et al.  High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity* , 2010, The Journal of Biological Chemistry.

[7]  M. Giovannini,et al.  Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. , 2010, Genes & development.

[8]  R. Schnellmann,et al.  Murine Kupffer Cells Are Protective in Total Hepatic Ischemia/Reperfusion Injury with Bowel Congestion through IL-10 , 2010, The Journal of Immunology.

[9]  G. Plitas,et al.  Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. , 2010, The Journal of clinical investigation.

[10]  Zhang Jinxiang,et al.  Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. , 2009, Biochemical and biophysical research communications.

[11]  Wenjing Zhang,et al.  c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer. , 2008, Carcinogenesis.

[12]  G. Cheng,et al.  Evidence for the Pivotal Role of Endogenous Toll-Like Receptor 4 Ligands in Liver Ischemia and Reperfusion Injury , 2008, Transplantation.

[13]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[14]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[15]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[16]  M. Lotze,et al.  Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.

[17]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[18]  Ryan M. O’Connell,et al.  Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.

[19]  T. Billiar,et al.  TISSUE HYPOXIA ACTIVATES JNK IN THE LIVER DURING HEMORRHAGIC SHOCK , 2004, Shock.

[20]  I. Salmon,et al.  The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. , 2004, Transplantation proceedings.

[21]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[22]  R. Busuttil,et al.  Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.

[23]  J. Oyama,et al.  Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice , 2003, Circulation.

[24]  G. Su,et al.  Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[25]  Elisabeth L. Humphris,et al.  Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide , 2002, Infection and Immunity.

[26]  Y. Morishita,et al.  P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. , 2002, Surgery.

[27]  H. Rüdiger,et al.  Mechanism of hepatocyte death after ischemia: Apoptosis versus necrosis , 2001, Hepatology.

[28]  M. Magnuson,et al.  DNA excision in liver by an albumin‐Cre transgene occurs progressively with age , 2000, Genesis.

[29]  J. Engelhardt,et al.  Therapeutic approaches for ischemia/reperfusion injury in the liver , 1999, Journal of Molecular Medicine.

[30]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[31]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[32]  T. Tani,et al.  JNK activation and apoptosis during ischemia-reperfusion. , 1999, Transplantation proceedings.

[33]  D. Brenner,et al.  Reperfusion after liver transplantation in rats differentially activates the mitogen‐activated protein kinases , 1997, Hepatology.

[34]  R. Palmiter,et al.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. , 1987, Genes & development.

[35]  N. Shiojiri Enzymo- and immunocytochemical analyses of the differentiation of liver cells in the prenatal mouse. , 1981, Journal of embryology and experimental morphology.

[36]  J. Wang,et al.  Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. , 1978, Science.

[37]  J. Hughes,et al.  Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.